Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

Autor: Adrian Murray Brunt, Joanne S Haviland, Duncan A Wheatley, Mark A Sydenham, Abdulla Alhasso, David J Bloomfield, Charlie Chan, Mark Churn, Susan Cleator, Charlotte E Coles, Andrew Goodman, Adrian Harnett, Penelope Hopwood, Anna M Kirby, Cliona C Kirwan, Carolyn Morris, Zohal Nabi, Elinor Sawyer, Navita Somaiah, Liba Stones, Isabel Syndikus, Judith M Bliss, John R Yarnold, Anne Armstrong, Judith Bliss, David Bloomfield, Jo Bowen, Murray Brunt, Hannah Chantler, Charlotte Coles, Ellen Donovan, Andy Goodman, Susan Griffin, Jo Haviland, Penny Hopwood, Anna Kirby, Julie Kirk, Cliona Kirwan, Marjory MacLennan, Mark Sculphur, Judith Sinclair, Mark Sydenham, Jean Tremlett, Karen Venables, Duncan Wheatley, John Yarnold

Publikováno v: Lancet (London, England)
FAST-Forward Trial Management Group 2020, ' Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward) : 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial ', Lancet (London, England), vol. 395, no. 10237, pp. 1613-1626 . https://doi.org/10.1016/S0140-6736(20)30932-6

BACKGROUND: We aimed to identify a five-fraction schedule of adjuvant radiotherapy (radiation therapy) delivered in 1 week that is non-inferior in terms of local cancer control and is as safe as an international standard 15-fraction regimen after pri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53e395035946033bfb3c8db03e2d044a

Adrenocortical carcinoma, where's the delay?

Autor: Rob G. Dyer, Andy Goodman, Julie Dunn, Antonia Brooke, Aftab Aziz

Publikováno v: Endocrine Abstracts.

Introduction • Adrenocortical carcinomas are rare (incidence 1-2 per million), present late and have a poor prognosis (1). • Appropriate management of adrenal carcinomas involves collaboration within a multidisciplinary team (MDT) involving endoc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::541db2c35e14dd1efc926f0cb60f40d6
https://doi.org/10.1530/endoabs.34.p149

A Putative Type V Pilus Contributes to Bacteroides thetaiotaomicron Biofilm Formation Capacity

Autor: Philippe Langella, Christophe Beloin, Florian Chain, Christa Ivanova, Jovana Mihajlovic, Alexandre Almeida, Jean-Marc Ghigo, Nathalie Béchon

Publikováno v: Journal of Bacteriology
Journal of Bacteriology, 2019, 201 (18), pp.e00650-18. ⟨10.1128/JB.00650-18⟩
Journal of Bacteriology, American Society for Microbiology, 2019, 201 (18), pp.e00650-18. ⟨10.1128/JB.00650-18⟩

International audience; Bacteroides thetaiotaomicron is a prominent anaerobic member of the healthy human gut microbiota. While the majority of functional studies on B. thetaiotaomicron addressed its impact on the immune system and the utilization of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b504ba79eb8099e7b3edb11aea18221
https://doi.org/10.1128/jb.00650-18